ACAD vs VZ · P/E 15, rev $576.0M vs P/E 11, rev $34.25B
ACADIA Pharmaceuticals Inc (ACAD) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported VZ revenue for 2026-06-30 was $34.25B. Net income was $3.83B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the ACAD and VZ stock pages for the full models.
Not investment advice.